These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7036287)

  • 1. Specific active immunotherapy in lung cancer: the induction of long-lasting cellular responses to tumour-associated antigens.
    Stewart T; Hollinshead AC; Harris JE; Raman S
    Recent Results Cancer Res; 1982; 80():232-9. PubMed ID: 7036287
    [No Abstract]   [Full Text] [Related]  

  • 2. Specific active lung cancer immunotherapy. Immune correlates of clinical responses and an update of immunotherapy trials evaluations.
    Hollinshead A; Takita H; Stewart T; Raman S
    Cancer; 1988 Oct; 62(8):1662-71. PubMed ID: 3048633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure of specific active immunotherapy in lung cancer.
    Souter RG; Gill PG; Gunning AJ; Morris PJ
    Br J Cancer; 1981 Oct; 44(4):496-501. PubMed ID: 7028069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant specific active lung cancer immunotherapy trials. Tumor-associated antigens.
    Hollinshead A; Stewart TH; Takita H; Dalbow M; Concannon J
    Cancer; 1987 Sep; 60(6):1249-62. PubMed ID: 2441838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy for lung cancer.
    Bradbury PA; Shepherd FA
    J Thorac Oncol; 2008 Jun; 3(6 Suppl 2):S164-70. PubMed ID: 18520304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A preliminary trial of a novel form of active immunotherapy in squamous cell carcinoma of the lung.
    Lachmann PJ; Grant RM; Freedman LS; Sikora K; Bleehen NM
    Br J Cancer; 1985 Mar; 51(3):415-7. PubMed ID: 3882114
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunotherapy in lung cancer: "b7-bombers" and other new developments.
    Creelan BC; Antonia SJ
    Semin Respir Crit Care Med; 2013 Dec; 34(6):810-21. PubMed ID: 24258571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is vaccine therapy a renewed strategic approach for non-small-cell lung cancer therapy?
    Rossi A
    Expert Rev Vaccines; 2013 Jan; 12(1):5-7. PubMed ID: 23256734
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunotherapy in bronchial carcinoma].
    Havemann K
    Onkologie; 1980 Jun; 3(3):120-6. PubMed ID: 6258119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond the standard of care: a review of novel immunotherapy trials for the treatment of lung cancer.
    Hall RD; Gray JE; Chiappori AA
    Cancer Control; 2013 Jan; 20(1):22-31. PubMed ID: 23302904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific active immunochemotherapy in lung cancer: a survival study.
    Stewart TH; Hollinshead AC; Harris JE; Raman S; Bélanger R; Crépeau A; Crook AF; Hirte WE; Hooper D; Klaassen DJ; Rapp EF; Sachs HJ
    Can J Surg; 1977 Jul; 20(4):370-7. PubMed ID: 301428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrapleural BCG immunotherapy of lung cancer patients.
    Maver C; Kausel H; Lininger L; McKneally M
    Recent Results Cancer Res; 1982; 80():227-31. PubMed ID: 7036286
    [No Abstract]   [Full Text] [Related]  

  • 13. Active, specific immunotherapy for lung cancer: hurdles and strategies using genetic modification.
    Korst RJ; Crystal RG
    Ann Thorac Surg; 2003 Oct; 76(4):1319-26. PubMed ID: 14530047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MAGE A3 antigen-specific cancer immunotherapeutic.
    Peled N; Oton AB; Hirsch FR; Bunn P
    Immunotherapy; 2009 Jan; 1(1):19-25. PubMed ID: 20635969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical trials targeting lung cancer with active immunotherapy: the scope of vaccines.
    Raez LE; Santos ES; Mudad R; Podack ER
    Expert Rev Anticancer Ther; 2005 Aug; 5(4):635-44. PubMed ID: 16111464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Belagenpumatucel-L for the treatment of non-small cell lung cancer.
    Rijavec E; Biello F; Genova C; Barletta G; Maggioni C; Dal Bello MG; Coco S; Truini A; Vanni I; Alama A; Beltramini S; Grassi MA; Boccardo F; Grossi F
    Expert Opin Biol Ther; 2015; 15(9):1371-9. PubMed ID: 26211534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer testis antigens: a novel target in lung cancer.
    Chiriva-Internati M; Pandey A; Saba R; Kim M; Saadeh C; Lukman T; Chiaramonte R; Jenkins M; Cobos E; Jumper C; Alalawi R
    Int Rev Immunol; 2012 Oct; 31(5):321-43. PubMed ID: 23083344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy and lung cancer: current developments and novel targeted therapies.
    Domingues D; Turner A; Silva MD; Marques DS; Mellidez JC; Wannesson L; Mountzios G; de Mello RA
    Immunotherapy; 2014; 6(11):1221-35. PubMed ID: 25496336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologically defined prognostic subgroups as predictors of response to BCG immunotherapy.
    Reid JW; Cannon GB; Perlin E; Blom J; Connor R; Herberman RB
    Recent Results Cancer Res; 1982; 80():219-26. PubMed ID: 7036285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant immunotherapy in bronchogenic carcinoma.
    Takita H; Minowada J; Han T; Takada M; Lane WW
    Ann N Y Acad Sci; 1976; 277(00):345-54. PubMed ID: 1069554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.